STOCK TITAN

Cycurion Q3 revenue rises 40% to $5.4M; losses narrow

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Cycurion, Inc. reported third-quarter 2026 revenue of $5.4 million, up 40% from $3.8 million a year earlier, and gross profit of $1.9 million versus $0.3 million; gross margin was 36%, compared with 7%. Operating loss narrowed 35% to $3.0 million, while adjusted EBITDA loss, a non-GAAP measure, narrowed 64% to $1.2 million.

For the nine months ended September 30, 2026, revenue rose 7% to $12.4 million and net loss narrowed to $9.7 million from $18.8 million; adjusted EBITDA loss was $4.6 million versus $4.1 million. Cash and cash equivalents were $3.0 million as of September 30, 2026, and net cash used in operating activities was $7.8 million for the nine months. Cycurion disclosed continuing going-concern uncertainty and a $10.5 million working capital deficit. Its 10-year, $54.6 million state health and human services award is expected to begin at the end of the first quarter of 2027.

4 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

How the balance works

Positive

  • Moderate pointThird-quarter revenue increased 40% to $5.4 million.
  • Moderate pointThird-quarter gross profit was $1.9 million, versus $0.3 million.
  • Moderate pointQuarterly adjusted EBITDA loss narrowed 64% to $1.2 million.
  • Moderate pointNine-month net loss narrowed 48% to $9.7 million.

Negative

  • Major pointCycurion disclosed going-concern uncertainty alongside a $10.5 million working capital deficit.
  • Moderate pointNine-month adjusted EBITDA loss was $4.6 million, versus $4.1 million a year earlier.

Filing Explained

The release reports that a substantial portion of notes converted into common stock in July and August; shares outstanding were 3,620,618 at September 30, 2026, versus 455,308 at December 31, 2025; issuing shares reduces existing holders’ percentage ownership.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Third-quarter revenue $5.4 million Third quarter ended September 30, 2026; $3.8 million in the prior-year quarter; up 40%.
Third-quarter gross profit $1.9 million Third quarter ended September 30, 2026; $0.3 million in the prior-year quarter.
Third-quarter gross margin 36% Third quarter ended September 30, 2026; 7% in the prior-year quarter.
Third-quarter adjusted EBITDA loss $1.2 million Third quarter ended September 30, 2026; $3.3 million in the prior-year quarter.
Nine-month revenue $12.4 million Nine months ended September 30, 2026; $11.6 million in the prior-year period; up 7%.
Nine-month net loss $9.7 million Nine months ended September 30, 2026; $18.8 million in the prior-year period; improved 48%.
Working capital deficit $10.5 million At the end of the third quarter of 2026; $8.9 million as of December 31, 2025.
State health and human services award $54.6 million over 10 years Work is expected to commence at the end of the first quarter of 2027.
Adjusted EBITDA financial
"Adjusted EBITDA loss, a non-GAAP measure"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
working capital deficit financial
"working capital deficit of $10.5 million"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
going concern uncertainty financial
"continue to face going concern uncertainty"
A going concern uncertainty is an auditor’s warning that there is significant doubt about a company’s ability to stay in business and meet its obligations for the next year. For investors, it is like a red flag or low-fuel light on a car—indicating higher risk of bankruptcy, asset write-downs, or big changes to operations, which can sharply affect share value and investment decisions.
warrant inducement transaction financial
"through a warrant inducement transaction with an existing investor"
A warrant inducement transaction is when a company issues warrants—options to buy shares at a set price—as a sweetener to persuade investors or creditors to approve a deal, restructuring, or other corporate action. Think of it like giving coupons to convince people to agree to a plan; it can speed approvals but may dilute existing shareholders and change potential future share value, so investors watch these carefully.
risk prioritization technical
"Panoptic's risk prioritization"
predictive intelligence technical
"Predictive intelligence connects the portfolio"
Predictive intelligence uses large amounts of past and current data and advanced computer models to estimate likely future events or trends, such as sales, customer behavior, equipment failures or market movements. For investors it matters because these forecasts can highlight potential opportunities or risks earlier than plain observation, helping guide decisions on buying, selling or allocating capital much like a weather forecast helps plan a trip—useful for reducing uncertainty but not a guarantee.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did CYCU report in Q3 2026?

Cycurion reported third-quarter revenue of $5.4 million, up 40% from $3.8 million in the prior-year quarter. Gross profit was $1.9 million, compared with $0.3 million, and gross margin was 36%, versus 7%.

What is the value and expected start timing of Cycurion’s state health and human services award?

The award is valued at $54.6 million over a 10-year term, and work is expected to commence at the end of the first quarter of 2027.

How much of CYCU’s Q3 revenue increase came from acquisitions?

Acquisitions contributed approximately $1.2 million of the approximately $1.5 million year-over-year revenue increase. Existing operations contributed approximately $0.3 million, returning to growth after project roll-offs earlier in the year.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001868419false00018684192026-11-162026-11-160001868419us-gaap:CommonStockMember2026-11-162026-11-160001868419us-gaap:WarrantMember2026-11-162026-11-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 16, 2026
Image_1.jpg
Cycurion, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware001-4121486-3720717
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
1640 Boro Place, Suite 420C McLean, Virginia
(Address of principal executive offices)
22102
(Zip Code)
Registrant’s telephone number, including area code: (888) 341-6680
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stock, par value $0.0001 per shareCYCUThe NASDAQ Stock Market LLC
Redeemable warrants, each exercisable for one share of common stock at an exercise price of $345.00 per shareCYCUWThe NASDAQ Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 8.01 Other Events.
On November 16, 2026, the Company issued a press release. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits
(d)Exhibits:
Exhibit No.Description
99.1
Press Release dated November 16, 2026
104Inline XBRL for the cover page of this Current Report on Form 8-K
2


SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CYCURION, INC.
Date:November 16, 2026By:/s/ L. Kevin Kelly
Name:L. Kevin Kelly
Title:Chief Executive Officer
3


 
Exhibit 99.1
image_1a.jpg

Cycurion Reports Record Quarterly Revenue and Gross Profit as Revenue Grows 40% and Gross Margin Reaches 36%

Revenue exceeds Wall Street consensus estimate of $4.37 million
Gross Profit More Than Seven Times Prior Year • Operating Loss Narrows 35% • Adjusted EBITDA Loss Narrows 64%
McLean, Virginia – November 16, 2026 – Cycurion, Inc. (NASDAQ: CYCU) ("Cycurion" or the "Company"), a predictive cybersecurity company delivering AI-driven cybersecurity, national security, and public safety technology solutions, today announced its financial results for the third quarter ended September 30, 2026. The Company reported higher revenue and gross profit, with contributions from acquired businesses and a return to growth in existing operations.
Third Quarter 2026 Highlights
•Revenue increased 40% to $5.4 million, compared to $3.8 million in the prior-year quarter.
•Gross profit increased to $1.9 million, compared to $0.3 million in the prior year quarter, which is more than seven times the prior-year level. Gross margin expanded to 36% from 7%.
•Operating loss narrowed 35% to $3.0 million, compared to $4.5 million in the prior year quarter.
•Net loss improved 4% to $3.1 million, compared to $3.2 million in the prior year quarter; net loss attributable to Cycurion improved 6% to $2.9 million, compared to $3.1 million in the prior year quarter.
•Adjusted EBITDA loss, a non-GAAP measure, narrowed 64% to $1.2 million, compared to a loss of $3.3 million in the prior year quarter.
Management Commentary
"Our third-quarter results demonstrate the momentum we are building at Cycurion," said L. Kevin Kelly, Chairman and Chief Executive Officer. "Higher-margin revenue translated into substantially more gross profit, and we narrowed our operating and adjusted EBITDA losses. We also returned to revenue growth in our existing operations while adding contributions from our acquisitions. We are encouraged by this progress and focused on carrying it forward."
"We see a significant opportunity ahead. Our acquisitions have expanded our capabilities and customer reach, and our predictive intelligence strategy gives us more ways to help customers identify and address their most consequential threats. Our team, which includes veterans of the U.S. Intelligence Community and the private-sector cybersecurity industry, is focused on converting those opportunities into recurring revenue, stronger gross profit and continued progress toward profitability. We are building on a stronger operating foundation while maintaining expense discipline and working to improve operating cash flow."
Strategic and Operational Progress
•Growth from acquisitions and existing operations. Acquisitions contributed approximately $1.2 million of the approximately $1.5 million year-over-year revenue increase. Existing operations contributed approximately $0.3 million, returning to growth after project roll-offs earlier in the year.
•A broader platform and customer base. Recent acquisitions contributed to the quarter’s results, led by Cycurion Digital Ally Inc. (“Cycurion Digital Ally”), Kustom Entertainment Inc.’s former video solutions business acquired on August 3, 2026. Cycurion Digital Ally brings video and evidence technology and relationships with more than 800 public safety organizations



that Cycurion intends to use to cross-sell cybersecurity services. Secuvant, LLC (“Secuvant”), acquired in June 2026, also contributed its first full quarter of results and adds managed security services and the Panoptic cyber risk prioritization platform.
•Predictive intelligence connects the portfolio. On October 14, 2026, Cycurion relaunched as a predictive cybersecurity company. Its strategy is to connect threat signals with the systems and operations each customer depends on, helping security teams prioritize exposures and take action earlier. Panoptic's risk prioritization and Secuvant's managed security services support that approach.
•Habit advances security operations. On November 4, 2026, Cycurion launched Habit, an AI security operations center designed to learn each client’s normal behavior, surface deviations and assist with triage. The offering combines those capabilities with around-the-clock human analysts, offensive analysis and incident response. Management is focused on customer adoption and commercialization as part of its recurring service growth strategy.
•State health and human services program. Work under the Company’s 10-year, $54.6 million award to modernize and securely operate a state health and human services system is expected to commence at the end of the first quarter of 2027. The award value covers the full 10-year term.
Additional Financial Information
The third quarter 2026 delivered record revenue and gross profit results, higher gross margin and narrower net and adjusted EBITDA losses with higher margin acquisitions and organic growth driving these results.
The Company's reported net loss was $3.1 million, compared to $3.2 million in the prior year quarter. The prior-year quarter's net loss benefited from a one-time $2.0 million gain on debt settlement. Excluding that non-recurring gain from the prior year comparison, net loss improved 41% year-over-year. To give a clearer view of underlying operating performance, we also evaluate results using EBITDA and Adjusted EBITDA, which are non-GAAP measures. Reconciliations of net loss to EBITDA and Adjusted EBITDA are included in the financial schedules accompanying this release.
Net loss attributable to Cycurion was $2.9 million, or $1.03 per basic and diluted share, compared to $3.1 million, or $12.39 per basic share and $12.36 per diluted share in the prior-year quarter. Per-share amounts reflect the 1-for-8 reverse stock split effective August 28, 2026, applied retroactively to all periods presented.
Nine-Month 2026 Results
For the nine months ended September 30, 2026, revenue increased 7% to $12.4 million from $11.6 million, compared to the prior year period. Gross profit more than tripled to $3.7 million from $1.2 million in the prior year period, and gross margin expanded to 30% from 10%. Net loss improved 48% to $9.7 million from $18.8 million in the prior year period.
Adjusted EBITDA loss was $4.6 million, compared to $4.1 million in the prior year period, reflecting public-company costs, SLG Innovation, Inc. consolidation, key growth hires and the two 2026 acquisitions of Secuvant and Cycurion Digital Ally, partly offset by third-quarter revenue growth and improved gross margin.
Balance Sheet and Liquidity
As of September 30, 2026, cash and cash equivalents were $3.0 million, compared to $1.9 million as of June 30, 2026, and $3.7 million as of September 30, 2025. During the quarter, the Company raised $4.5 million in gross proceeds through a warrant inducement transaction with an existing investor. It used $1.5 million of those proceeds to fund acquisitions and the remainder to support working capital needs.
Net debt, a non-GAAP measure, was $5.3 million, compared to $5.2 million as of September 30, 2025, and $2.8 million as of December 31, 2025. The increase reflects a $4.3 million promissory note issued for the acquisition of Kustom's video solutions business, partially offset by conversions of a substantial portion of other notes into common stock during the months of July and August of 2026.
As disclosed in the Company's Quarterly Report on Form 10-Q, we continue to face going concern uncertainty. We ended the quarter with a working capital deficit of $10.5 million, up from $8.9 million as of December 31, 2025, driven mainly by the promissory note for the Cycurion Digital Ally acquisition and higher accounts payable tied to growth and public-company costs. Third-quarter revenue growth, improved gross margin, lower debt following note conversions and higher receivables and inventory partially offset the increase.
2



Outlook
Cycurion enters the fourth quarter with momentum, focused on building on its operating improvement. Work under the state health and human services contract is expected to begin at the end of the first quarter of 2027. Habit’s launch creates an additional commercialization opportunity. Management’s priorities are to integrate acquired operations, expand higher-margin recurring services and pursue cross-selling across the customer base while maintaining expense discipline. The objective is to grow gross profit faster than operating costs, continue narrowing losses and improve operating cash flow. The Company does not provide quarterly financial guidance.
Earnings Call
Cycurion will host an earnings call today, Monday, November 16, 2026, at 9:30 a.m. Eastern Time. Management will deliver prepared remarks and respond to questions that were submitted in advance. To view the live webcast, please register at https://edge.media-server.com/mmc/p/e3ncvmao. A replay and transcript will be available on the Company’s investor relations page at https://investors.cycurion.com/investor-faq following the call.
About Cycurion, Inc.
Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, Secuvant LLC, Cycurion Digital Ally Inc. and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. For more information, visit www.cycurion.com.
Forward-Looking Statements
Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. This cautionary statement also applies to forward-looking statements made by management during the Company’s earnings call to be held on November 16, 2026. Such statements include, but are not limited to, statements regarding the integration and expected contributions of acquired businesses, including Secuvant and Cycurion Digital Ally; opportunities to cross-sell services to existing and acquired customers, including public safety organizations; the adoption and commercialization of Habit and the execution of the Company’s predictive cybersecurity strategy; the acceleration of the Company’s inorganic growth strategy through potential acquisitions and strategic transactions; the continued execution of the Company’s contracted backlog; the commencement, ramp, timing, amount and likelihood of realizing revenues associated with our contracted backlog, including the Company’s 10-year state health and human services award; the Company’s objectives to grow recurring revenue and gross profit, narrow losses, improve operating cash flow and progress toward profitability; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “objective,” “opportunity,” and similar expressions intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, risks related to the Company’s ability to continue as a going concern, its working capital deficit and its ability to obtain financing on acceptable terms or at all, including potential dilution to stockholders; the Company’s indebtedness, including the promissory note issued in connection with the acquisition of Kustom Entertainment Inc.’s video solutions business; the Company’s ability to successfully integrate acquired businesses and realize their anticipated benefits; market acceptance of new offerings, including Habit; risks inherent in government contracting, including funding and appropriations and the possibility that award values are not fully realized; competition; the Company’s ability to maintain the listing of its common stock on Nasdaq; customer performance and satisfaction, contract modifications, delays or terminations, and the Company’s ability to fulfill contractual obligations, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission, including the risk factors and going-concern disclosures in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new
3


information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.
Non-GAAP Financial Measures
This release includes non-GAAP financial measures (EBITDA and Adjusted EBITDA). These measures are provided for supplemental informational purposes only and should not be considered substitutes for GAAP results. A reconciliation of net loss to EBITDA and Adjusted EBITDA is included in the Company’s full earnings materials filed with the SEC.
In addition to our results determined in accordance with U.S. GAAP, we believe the non-GAAP financial measures of EBITDA, and Adjusted EBITDA are useful in evaluating our operating performance. We believe that this non-GAAP financial information, when taken collectively with our GAAP results, may be helpful to readers of our financial statements because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results. The non-GAAP financial information is presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly-titled non-GAAP measures used by other companies. A reconciliation is provided below for each of these non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Cycurion believes that EBITDA and Adjusted EBITDA provide the Board of Directors, management and investors with a clear representation of the Company's core operating performance and trends, provide greater visibility into the long-term financial performance of the Company, and eliminate the impact of items that do not relate to the ongoing operating performance of the business. Cycurion believes these non-GAAP financial measures facilitate the comparison of the Company's operating performance on a consistent basis between periods by excluding certain items that may, or could, have a disproportionately positive or negative impact on the Company's results of operations in any particular period. When viewed in combination with the Company's results prepared in accordance with GAAP, these non-GAAP financial measures help provide a broader picture of factors and trends affecting the Company's results of operations. EBITDA and Adjusted EBITDA are supplemental measures of operating performance that are not made under GAAP and do not represent, and should not be considered as an alternative to net (loss)/income, earnings per share or operating expenses, as determined by GAAP. The Company defines EBITDA as net (loss)/income, adjusted for interest expense, provision for/(benefit from) income taxes, and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, adjusted for stock-based compensation expense, gain/(loss) on debt settlement, acquisition and transaction costs and other one-time expenses that are not part of the normal operating activities.
EBITDA and Adjusted EBITDA each has limitations as an analytical tool, and you should not consider any of them in isolation, or as a substitute for analysis of results as reported under GAAP. Other companies in the Company's industry may calculate Adjusted EBITDA differently than Cycurion does, which limits its usefulness as a comparative measure. Because of these limitations, neither EBITDA or Adjusted EBITDA should be considered as a replacement for net (loss)/income, or as a measure of profitability. Cycurion compensates for these limitations by relying primarily on the Company’s GAAP results and using non-GAAP measures only for supplemental purposes.
Cycurion Investor Relations:
(888) 341-6680
investors@cycurion.com
Cycurion Media Relations:
(888) 341-6680
media@cycurion.com
4


Non-GAAP Financial Measures
(Unaudited)


 Reconciliation of Net Loss to EBITDA (Non-GAAP) and Adjusted EBITDA (Non-GAAP)
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2026202520262025
Net Loss$(3,125,085)$(3,240,017)$(9,726,438)$(18,778,917)
Interest income(21,555)(1,770)(39,297)(1,770)
Interest expense179,819 712,374 612,612 1,506,657 
Depreciation and amortization— 24,749 — 45,321 
EBITDA (Non-GAAP)(2,966,821)(2,504,664)(9,153,123)(17,228,709)
(Gain)/loss on debt settlement, net (1)— (2,016,469)1,930,427 (1,250,139)
Transaction related expenses (2)28,500 (874,008)103,737 11,240,114 
One-time expenses (3)63,000 — 153,000 — 
Stock compensation expenses (4)1,687,250 2,082,000 2,339,805 3,094,443 
Adjusted EBITDA (Non-GAAP)$(1,188,071)$(3,313,141)$(4,626,154)$(4,144,291)

(1)(Gain)/loss on debt settlement, net represents the conversion of the promissory notes primarily related to the deemed issuance cost of preferred stock issued to satisfy default interest obligations.
(2)Acquisition and transaction/business combination costs generally represent professional fees and direct expenses related to acquisitions and public offerings.
(3)One-time expenses represent non-ordinary course costs in connection with a change in a contract or a change in the makeup of our personnel often related to an acquisition, such as severance payments, recruiting fees and retention charges.
(4)Stock compensation expense represents a portion of compensation paid to our employees and executives through stock-based instruments.
5


CYCURION, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2026
2025
20262025
Revenue$5,378,452 $3,833,038 $12,404,148 $11,591,003 
Cost of revenue3,454,160 3,562,559 8,698,161 10,406,824 
Gross profit1,924,292 270,479 3,705,987 1,184,179 
Operating expenses:
Selling, general and administrative expenses3,203,863 2,719,600 8,588,878 5,244,323 
Stock compensation expenses1,687,250 2,082,000 2,339,805 3,094,443 
Business combination expenses— — — 11,240,114 
Total operating expenses4,891,113 4,801,600 10,928,683 19,578,880 
Operating loss(2,966,821)(4,531,121)(7,222,696)(18,394,701)
Other income/(expenses):
Interest income21,555 1,770 39,297 1,770 
Interest expense(179,819)(712,374)(612,612)(1,506,657)
Gain/(loss) on debt settlement, net— 2,016,469 (1,930,427)1,250,139 
Other expense, net— (14,761)— (129,468)
Other (expenses)/income, net(158,264)1,291,104 (2,503,742)(384,216)
Loss before income taxes(3,125,085)(3,240,017)(9,726,438)(18,778,917)
Provision for income tax— — — — 
Net loss(3,125,085)(3,240,017)(9,726,438)(18,778,917)
Less: Net loss attributable to non-controlling interest202,238 116,700 919,355 218,359 
Net loss attributable to Cycurion$(2,922,847)$(3,123,317)$(8,807,083)$(18,560,558)
Comprehensive loss$(2,922,847)$(3,123,317)$(8,807,083)$(18,560,558)
Loss per share:
Basic$(1.03)$(12.39)$(5.80)$(114.40)
Diluted$(1.03)$(12.36)$(5.80)$(113.85)
Weighted average shares outstanding:
Basic2,826,145252,0531,518,128162,247
Diluted2,826,145252,4731,518,128162,667
6


CYCURION, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
September 30,
2026
December 31,
2025
Assets:
Cash and cash equivalents$2,982,927 $5,255,235 
Accounts receivable, net4,003,712 2,687,479 
Prepaid expenses and other current assets330,712 60,133 
Inventory1,756,642 — 
Other receivables— — 
Total current assets9,073,993 8,002,847 
Software development costs, net4,891,981 4,606,981 
Goodwill and intangibles33,537,443 20,842,508 
Other assets - non-current491,044 — 
Total non-current assets38,920,468 25,449,489 
Total assets$47,994,461 $33,452,336 
Liabilities and Stockholders' Equity:
Liabilities:
Bank loan-revolving credit line$2,421,305 $2,933,396 
Loans payable - current portion269,068 669,693 
Factoring liability985,214 1,511,678 
Convertible notes76,609 192,897 
Promissory notes2,419,812 2,499,662 
Loans payable - related parties— 123,650 
Accounts payable1,476,357 1,314,772 
Accrued liabilities8,015,096 4,228,337 
Accrued compensation and benefits1,413,471 919,825 
Contract liabilities - current portion1,015,130 — 
Accrued interest payable278,001 1,347,787 
Excise tax payable1,167,173 1,167,173 
Total current liabilities19,537,236 16,908,870 
Contract liabilities - non-current portion1,237,191 — 
Loans payable - non-current portion2,815,394 300,000 
Total non-current liabilities4,052,585 300,000 
Total liabilities23,589,821 17,208,870 
Stockholders' Equity:
Preferred stock ($0.0001 par value, 20,000,000 shares authorized)
Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 0 and 0 issued and outstanding, respectively)
— — 
Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 0 and 1 issued and outstanding, respectively)
— — 
Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 2,547 and 4,851 issued and outstanding, respectively)
— — 
Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 150,000 issued and outstanding, respectively)
15 15 
Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 51 issued and outstanding, respectively)
— — 
Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively)
— — 
Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 143 and 143 issued and outstanding, respectively)
——
Series H convertible preferred stock ($0.0001 par value, 10,000 shares designated, 2,172 and 0 issued and outstanding, respectively)
— — 
Series I convertible preferred stock ($0.0001 par value, 888,888 shares designated, 888,888 and 0 issued and outstanding, respectively)
89 — 
Common stock ($0.0001 par value, 300,000,000 shares authorized, 3,620,618 and 455,308 shares issued and outstanding, respectively)
362 46 
Additional paid in capital64,867,287 46,980,080 
Accumulated deficit(35,686,164)(26,879,081)
Total stockholders' equity attributable to Cycurion29,181,589 20,101,060 
Deficit attributable to noncontrolling interests(4,776,949)(3,857,594)
Total stockholders' equity24,404,640 16,243,466 
Total liabilities and stockholders’ equity$47,994,461 $33,452,336 
7


CYCURION, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

For the Nine Months Ended September 30,
20262025
Cash flows from operating activities:
Net loss$(9,726,438)$(18,778,917)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock compensation expenses2,339,805 3,094,443 
Stock-based compensation - business combination related- 9,521,734 
Amortization of debt discount1,187 234,430 
Recovery of credit losses(130,365)- 
Depreciation of property and equipment- 20,321 
Amortization of software costs- 25,000 
Loss/(gain) on debt settlement, net1,930,427 (1,250,139)
Finance expense- 100,000 
Changes in assets and liabilities:
Accounts receivable, net and other receivables(242,908)(286,701)
Prepaid expenses and other current assets(152,486)42,326 
Accounts payable and accrued liabilities(1,698,365)(1,524,012)
Accrued compensation and benefits(212,795)104,518 
Contract assets and liabilities, net(204,291)- 
Accrued interest payable286,848 (74,922)
Net cash used in operating activities(7,809,381)(8,771,919)
Cash flows from investing activities:
Net cash disbursed on business combinations(1,566,986)34,983 
Capitalized software development costs(285,000)(268,000)
Cash withdrawn from Trust Account in connection with redemption- 1,001,216 
Release of Trust Account to Company's bank account- 833,324 
Net cash (used in)/provided by investing activities(1,851,986)1,601,523 
Cash flows from financing activities:
Proceeds from exercise of warrants, net3,845,453 3,664,871 
Redemption of common stock subject to redemption- (1,001,216)
Proceeds from capital raise4,067,728 5,874,584 
Repayments of revolving line of credit(512,091)(18,000)
Repayment of bank borrowings- (499,180)
Proceeds from convertible notes payable- 2,376,500 
Proceeds from notes payable- 513,200 
Repayments of notes payable(12,031)(101,579)
Net cash provided by financing activities7,389,059 10,809,180 
Net (decrease)/increase in cash and cash equivalents(2,272,308)3,638,784 
Cash and cash equivalents, beginning of period5,255,235 40,790 
Cash and cash equivalents, end of period$2,982,927 $3,679,574 





8

Filing Exhibits & Attachments

5 documents

Keep reading